The characteristics of side effects of different modes of chemotherapy for breast cancer by Bondarenko I.M., Phokhach A.V.

Subjects: Get full text

The characteristics of side effects of different modes of chemotherapy for breast cancer. by I. M. Bondarenko, A. V. Phokhach

Subjects: Get full text

A single center retrospective study on real world CAR T-cell therapy: focus on early hematological toxicity by Vadim Lesan, Konstantinos Christofyllakis, Moritz Bewarder, Lorenz Thurner, Jörg Bittenbring

Subjects: Get full text

New insights into CAR T-cell hematological toxicities: manifestations, mechanisms, and effective management strategies by Yuanyuan Yang, Hongwei Peng, Jianxiang Wang, Fei Li

Subjects: Get full text

Effect of trilaciclib administered before chemotherapy in patients with extensive-stage small-cell lung cancer: A pooled analysis of four randomized studies by Ying Liu, Lin Wu, Dingzhi Huang, Qiming Wang, Chen Yang, Li Zhou, Shuguang Sun, Xiaomei Jiang, Ying Cheng

Subjects: Get full text

A case of atypical prolonged hematologic toxicity with azacitidine in Chronic Myelomonocytic Leukemia (CMML), review of literature and a proposal of management by Elena Elli, Caterina Cecchetti, Angelo Belotti, Lorenza Borin, Enrico Maria Pogliani

Subjects: Get full text

A case of atypical prolonged hematologic toxicity with azacitidine in Chronic Myelomonocytic Leukemia (CMML), review of literature and a proposal of management by Elena Elli, Caterina Cecchetti, Angelo Belotti, Lorenza Borin, Enrico Maria Pogliani

Subjects: Get full text

Hematological toxicities in PARP inhibitors: A real‐world study using FDA adverse event reporting system (FAERS) database by Yamin Shu, Yufeng Ding, Xucheng He, Yanxin Liu, Pan Wu, Qilin Zhang

Subjects: Get full text

Molecular Mechanisms of Synergistic Effect of PRIMA‐1met and Oxaliplatin in Colorectal Cancer With Different p53 Status by Xiao‐lan Li, Jianbiao Zhou, Nicole Xin‐Ning Tang, Yi Chai, Meng Zhou, Ai‐di Gao, Zhong‐kai Lu, Han Min

Subjects: Get full text